Shares of Regeneron Pharmaceuticals rose as much as 7.4% on Thursday after the company reported better-than-expected sales for the first quarter. The Tarrytown, N.Y.-based biopharmaceutical firm had revenue of $1.32 billion, up 10% compared to the same period last year.
http://ift.tt/2pF6KaH
No comments:
Post a Comment